Movement disorders : official journal of the Movement Disorder Society
LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease.
Anthony E Lang, Robert A Hauser, Lorraine V Kalia, Bonnie Hersh, Zdenek Berger, Roy Llorens Arenas, Coro Paisan-Ruiz, Kyle Fraser, Danna Jennings, Jillian H Kluss, Sarah Huntwork-Rodriguez, Anastasia G Henry, J Timothy Greenamyre
Published: 202510.1002/mds.70100
Abstract
A growing understanding of the role that leucine-rich repeat kinase 2 (LRRK2) plays in Parkinson's disease (PD) supports continued focus on this enzyme as a therapeutic target for PD. Accumulating evidence suggests that there are phenotypic, neuropat…
Preview only. Read the full abstract at the source